Issued Patents All Time
Showing 25 most recent of 54 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11851680 | Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR) | Aaron Martin, Michelle Brenda Pires | 2023-12-26 |
| 11453861 | Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR) | Aaron Martin, Michelle Brenda Pires | 2022-09-27 |
| 11384335 | Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR) | Aaron Martin | 2022-07-12 |
| 11186822 | Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR) | Aaron Martin | 2021-11-30 |
| 11008548 | Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR) | Aaron Martin, Michelle Brenda Pires | 2021-05-18 |
| 10138483 | Transferrin/transferrin receptor-mediated siRNA delivery | Abbot F. Clark | 2018-11-27 |
| 9932584 | Interfering RNA delivery system and uses thereof | Ying Yu | 2018-04-03 |
| 9795684 | Interfering RNA delivery system and uses thereof | — | 2017-10-24 |
| 9765340 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders | John M. Yanni, Daniel A. Gamache, Steven T. Miller | 2017-09-19 |
| 9752147 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions | Abbot F. Clark, Martin B. Wax | 2017-09-05 |
| 9745585 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Daniel A. Gamache, Steven T. Miller | 2017-08-29 |
| 9562230 | Transferrin/transferrin receptor-mediated siRNA delivery | Abbot F. Clark | 2017-02-07 |
| 9550994 | RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma | Abbot F. Clark, Wan-Heng Wang, Loretta McNatt | 2017-01-24 |
| 9526799 | Low density lipoprotein receptor-mediated siRNA delivery | — | 2016-12-27 |
| 9476047 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions | Abbot F. Clark, Martin B. Wax | 2016-10-25 |
| 9447419 | RNAi-mediated inhibition of tumor necrosis factor α-related conditions | John M. Yanni, Diane Michelle Senchyna, Daniel A. Gamache, Steven T. Miller | 2016-09-20 |
| 9422556 | RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis | Abbot F. Clark, David P. Bingaman, Martin B. Wax, Adrian M. Timmers | 2016-08-23 |
| 9371529 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | John M. Yanni, Daniel A. Gamache, Steven T. Miller | 2016-06-21 |
| 9347062 | Interfering RNA delivery system and uses thereof | Ying Yu | 2016-05-24 |
| 9289514 | Low density lipoprotein receptor-mediated siRNA delivery | — | 2016-03-22 |
| 9233170 | Interfering RNA delivery system and uses thereof | — | 2016-01-12 |
| 9206428 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Daniel A. Gamache, Steven T. Miller | 2015-12-08 |
| 9173896 | RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions | Abbot F. Clark, Martin B. Wax | 2015-11-03 |
| 9150862 | siRNA targeting VEGFA and methods for treatment in vivo | Anja Smith, Angela Reynolds, Xinyu Zhang | 2015-10-06 |
| 9139834 | RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis | Abbot F. Clark, David P. Bingaman, Martin B. Wax, Adrian M. Timmers | 2015-09-22 |